Arsenic drug combo resurrects 'guardian of the genome' to fight aggressive blood cancers
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Exercise can sometimes cause chest pain—and this condition may be to blame
United Kingdom
-
Analysis of 244 million Americans refines the understanding of long COVID
United Kingdom
-
Generativity vs. Stagnation in Psychosocial Development
United Kingdom
-
Dolores Huerta, influential labor leader, feminist and civil rights icon, dies at 96
United States
-
Unifying mechanism explains how common cancer mutations fuel growth
United Kingdom
-
How the heart's unusual carbohydrate metabolism helps it stay strong
United Kingdom
-
Who uses nicotine pouches?
United Kingdom
-
Brain scans challenge link between prefrontal activity and ability to regulate emotions
United Kingdom